loading...
2020 National IAS–USA Virtual Update Course on HIV Management
Presentation Slides Update From Our Nation's Capital, ID Week, and OI Guidelines Henry Masur, MD PrEP in the Era of COVID-19: A Case-Based Discussion Expert Panelists: Roger Bedimo, MD, MS, Connie L. Celum, MD, MPH, E. Turner Overton, MD, and Michael S. Saag, MD Case Presenter: Monica Gandhi, MD, MPH Projected Health Policy Changes in [...]
DETAIL
2020 IAS–USA Guidelines: Drugs for Treatment and Prevention of HIV Infection in Adults
Presentations Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel Covid-19 Update: Including the Intersection of HIV Rajesh T. Gandhi, MD
DETAIL
IAS–USA Virtual Update on HIV: Antiretroviral Therapy, New ART Drugs and Strategies, and the Intersection of COVID-19 and HIV — July 30, 2020
Presentations Investigational New Antiretroviral Drugs and Strategies Babafemi O. Taiwo, MBBS Interactive Antiretroviral Therapy Cases Joseph J. Eron, Jr, MD COVID-19: Update on Therapy and Vaccine Research Constance A. Benson, MD Preexposure Prophylaxis: Cases and Common Questions Susan P. Buchbinder, MD HIV and Opioid Use: The Intersection of the Co-Epidemics in the Midwest Sally L. [...]
DETAIL
IAS–USA Virtual Update on HIV: Antiretroviral Therapy, New ART Drugs and Strategies, and the Intersection of COVID-19 and HIV — July 14, 2020
Presentations Update From IAS 2020 Jeffrey L. Lennox, MD Interactive Antiretroviral Therapy Cases From the Clinic(ians) and Panel Discussion Michael S. Saag, MD Multidimenstional Challenges of COVID-19, Including COVID-19 and HIV Rajesh T. Gandhi, MD Preexposure Prophylaxis: Cases and Common Questions Susan P. Buchbinder, MD Why COVID-19 Will Not Mean the End of the STI [...]
DETAIL